全文获取类型
收费全文 | 37448篇 |
免费 | 3239篇 |
国内免费 | 3421篇 |
出版年
2024年 | 57篇 |
2023年 | 464篇 |
2022年 | 638篇 |
2021年 | 1848篇 |
2020年 | 1345篇 |
2019年 | 1588篇 |
2018年 | 1490篇 |
2017年 | 1134篇 |
2016年 | 1586篇 |
2015年 | 2372篇 |
2014年 | 2780篇 |
2013年 | 2930篇 |
2012年 | 3655篇 |
2011年 | 3126篇 |
2010年 | 1973篇 |
2009年 | 1667篇 |
2008年 | 2129篇 |
2007年 | 1802篇 |
2006年 | 1667篇 |
2005年 | 1376篇 |
2004年 | 1135篇 |
2003年 | 980篇 |
2002年 | 848篇 |
2001年 | 686篇 |
2000年 | 556篇 |
1999年 | 588篇 |
1998年 | 379篇 |
1997年 | 322篇 |
1996年 | 338篇 |
1995年 | 288篇 |
1994年 | 343篇 |
1993年 | 210篇 |
1992年 | 289篇 |
1991年 | 250篇 |
1990年 | 214篇 |
1989年 | 156篇 |
1988年 | 113篇 |
1987年 | 105篇 |
1986年 | 76篇 |
1985年 | 95篇 |
1984年 | 64篇 |
1983年 | 50篇 |
1982年 | 48篇 |
1981年 | 37篇 |
1980年 | 25篇 |
1979年 | 32篇 |
1978年 | 25篇 |
1976年 | 26篇 |
1975年 | 26篇 |
1973年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
951.
Yaping Hao Jian Zhou Mi Zhou Xiaojing Ma Zhigang Lu Meifang Gao Xiaoping Pan Junling Tang Yuqian Bao Weiping Jia 《PloS one》2013,8(8)
Background
The fibroblast growth factor 19 (FGF19) has been implicated in recent studies as a potential regulator of glucose and lipid metabolism, which may lead to atherosclerosis. Here, we investigated the association of FGF19 with the presence and severity of coronary artery disease (CAD) in a Chinese population.Methods
A total of 315 patients with suspected or established CAD, including 205 males and 110 postmenopausal females, were enrolled and assessed by coronary angiography. CAD severity was determined by the Gensini score. Serum FGF19 was measured by quantitative sandwich ELISA.Results
FGF19 levels were not significantly different between male and female patients (median [interquartile range], 143.40 [87.96–250.80] vs. 141.60 [87.13–226.32] pg/mL, P = 0.773). CAD patients had lower levels of FGF19 than those without CAD (128.20 [80.62–226.58] vs. 188.00 [105.10–284.70] pg/mL, P = 0.007). FGF19 was negatively correlated with 2hPG (r = –0.150, P = 0.008), FINS (r = –0.169, P = 0.004), HOMA-IR (r = –0.171, P = 0.004), and the Gensini score (r = –0.141, P = 0.012), but positively correlated with HDL-c (r = 0.116, P = 0.041) and adiponectin (r = 0.128, P = 0.024). Moreover, FGF19 was found to be independently correlated with 2hPG (β = –0.146, P = 0.022) and adiponectin (β = 0.154, P = 0.016). After adjusting for other CAD risk factors, FGF19 was demonstrated to be an independent factor for Gensini score (β = –0.140, P = 0.019) and the presence of CAD (β = –1.248, P = 0.036).Conclusions
Serum FGF19 is associated with the presence and severity of CAD in a Chinese population. 相似文献952.
Ying Lu Qiao Zhou Yongbing Shi Jian Liu Fang Zhong Xu Hao Cong Li Nan Chen Weiming Wang 《PloS one》2013,8(11)
Rosiglitazone (RGL), a synthetic agonist for peroxisome proliferator activated receptor γ (PPARγ), exhibits a potent anti-inflammatory activity by attenuating local infiltration of neutrophils and monocytes in the renal interstitium. To evaluate the mechanisms that account for inhibiting inflammatory cells infiltration, we investigated the effect of RGL on chemokines secretion and nuclear factor-kappa B (NF-κB) activation in human renal proximal tubular cells (PTCs). We demonstrated that RGL significantly inhibited lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) production in a dose-dependent manner, without appreciable cytotoxicity. Chromatin immunoprecipitation (ChIP) assays clearly revealed that, RGL inhibited p65 binding to IL-8/MCP-1 gene promoters in LPS-stimulated PTCs. Interestingly, further experiments showed RGL reversed LPS-induced nuclear receptor corepressor (NCoR) degradation. In addition, knockdown of protein inhibitor of activated STAT1 (PIAS1), an indispensable small ubiquitin-like modifier (SUMO) ligase, abrogated the effects of RGL on antagonizing LPS-induced IL-8/MCP-1 overexpression and NCoR degradation. These findings suggest that, RGL activates PPARγ SUMOylation, inhibiting NCoR degradation and NF-κB activation in LPS-stimulated PTCs, which in turn decrease chemokines expression. The results unveil a new mechanism triggered by RGL for prevention of tubular inflammatory injury. 相似文献
953.
Miaofei Xu Yufeng Qin Jianhua Qu Chuncheng Lu Ying Wang Wei Wu Ling Song Shoulin Wang Feng Chen Hongbing Shen Jiahao Sha Zhibin Hu Yankai Xia Xinru Wang 《PloS one》2013,8(11)
Background
Oligozoospermia is one of the severe forms of idiopathic male infertility. However, its pathology is largely unknown, and few genetic factors have been defined. Our previous genome-wide association study (GWAS) has identified four risk loci for non-obstructive azoospermia (NOA).Objective
To investigate the potentially functional genetic variants (including not only common variants, but also less-common and rare variants) of these loci on spermatogenic impairment, especially oligozoospermia.Design, Setting, and Participants
A total of 784 individuals with oligozoospermia and 592 healthy controls were recruited to this study from March 2004 and January 2011.Measurements
We conducted a two-stage study to explore the association between oligozoospermia and new makers near NOA risk loci. In the first stage, we used next generation sequencing (NGS) in 96 oligozoospermia cases and 96 healthy controls to screen oligozoospermia-susceptible genetic variants. Next, we validated these variants in a large cohort containing 688 cases and 496 controls by SNPscan for high-throughput Single Nucleotide Polymorphism (SNP) genotyping.Results and Limitations
Totally, we observed seven oligozoospermia associated variants (rs3791185 and rs2232015 in PRMT6, rs146039840 and rs11046992 in Sox5, rs1129332 in PEX10, rs3197744 in SIRPA, rs1048055 in SIRPG) in the first stage. In the validation stage, rs3197744 in SIRPA and rs11046992 in Sox5 were associated with increased risk of oligozoospermia with an odds ratio (OR) of 4.62 (P = 0.005, 95%CI 1.58-13.4) and 1.82 (P = 0.005, 95%CI 1.01-1.64), respectively. Further investigation in larger populations and functional characterizations are needed to validate our findings.Conclusions
Our study provides evidence of independent oligozoospermia risk alleles driven by variants in the potentially functional regions of genes discovered by GWAS. Our findings suggest that integrating sequence data with large-scale genotyping will serve as an effective strategy for discovering risk alleles in the future. 相似文献954.
955.
956.
957.
Chung-Feng Hwang Li-Yen Shiu Li-Jen Su Yu-Fang Yin Wei-Sheng Wang Shun-Chen Huang Tai-Jan Chiu Chao-Cheng Huang Yen-Yi Zhen Hsin-Ting Tsai Fu-Min Fang Tai-Lin Huang Chang-Han Chen 《PloS one》2013,8(12)
Background
Nasopharyngeal carcinoma (NPC) is known for its high metastatic potential and locoregional recurrence, although the molecular alterations that are driving NPC metastasis remain unclear at this time. This study aimed to examine the expression of fibulin-5 in NPC, correlate the results with clinicopathological variables and survival, and to investigate the role of fibulin-5 in human NPC cell lines.Material and Methods
Standard semi-quantitative-RT-PCR, quantitative-RT-PCR, immunoblotting, and immunohistochemistry were used to investigate the mRNA and protein expression profiles of fibulin-5 in normal and NPC tissues. Immunohistochemistry of fibulin-5 was correlated with clinicopathological characteristics by univariate analyses. NPC cells overexpressing fibulin-5 or fibulin-5-siRNA cells were generated by stable transfection to characterize the molecular mechanisms of fibulin-5-elicited cell growth and metastasis.Results
Our results demonstrated that fibulin-5 overexpression in NPC specimens and significantly correlated with advanced tumor metastasis indicating a poor 5-year overall survival. Fibulin-5 was mainly expressed in the nucleus in human NPC specimens and cell lines. Functionally, fibulin-5 overexpression yielded fast growth in NPC cells. In addition, fibulin-5 promotes cell metastasis in NPC cells through increased FLJ10540 and phosphor-AKT activity. In contrast, siRNA depletion of fibulin-5 suppressed FLJ10540 expression and phosphor-AKT activity. Suppression of either fibulin-5 or FLJ10540 can cause significant inhibition with regards to cell motility in NPC cells. Finally, immunohistochemical analysis of human aggressive NPC specimens showed a significant and positive correlation between fibulin-5 and FLJ10540 expression.Conclusion
Higher fibulin-5 expression is not only an important indicator of poor survival, but also contributes to the development of new therapeutic strategies in the FLJ10540/AKT pathway for NPC treatment. 相似文献958.
Fang Lu Lulin Huang Chuntao Lei Guiquan Sha Hong Zheng Xiaoqi Liu Jiyun Yang Yi Shi Ying Lin Bo Gong Xianjun Zhu Shi Ma Lifeng Qiao He Lin Jing Cheng Zhenglin Yang 《PloS one》2013,8(11)
Purpose
This study was intended to identify the disease causing genes in a large Chinese family with autosomal dominant retinitis pigmentosa and macular degeneration.Methods
A genome scan analysis was conducted in this family for disease gene preliminary mapping. Snapshot analysis of selected SNPs for two-point LOD score analysis for candidate gene filter. Candidate gene PRPF31 whole exons'' sequencing was executed to identify mutations.Results
A novel nonsense mutation caused by an insertion was found in PRPF31 gene. All the 19 RP patients in 1085 family are carrying this heterozygous nonsense mutation. The nonsense mutation is in PRPF31 gene exon9 at chr19:54629961-54629961, inserting nucleotide “A” that generates the coding protein frame shift from p.307 and early termination at p.322 in the snoRNA binding domain (NOP domain).Conclusion
This report is the first to associate PRPF31 gene''s nonsense mutation and adRP and JMD. Our findings revealed that PRPF31 can lead to different clinical phenotypes in the same family, resulting either in adRP or syndrome of adRP and JMD. We believe our identification of the novel “A” insertion mutation in exon9 at chr19:54629961-54629961 in PRPF31 can provide further genetic evidence for clinical test for adRP and JMD. 相似文献959.
960.